06/29/22 8:00 AMNYSE : GSK GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma CommunityGSK plc today announced the first recipient of the Target the Future Think Tank Challenge £70,000 grant to the HealthTree Foundation, a non-profit organization helping patients learn more about their health and become their own best advocates. GSK’ s grant will help support the HealthTree Foundation as it develops digital delivery tools to distribute...RHEA-AIvery positive
06/06/22 10:00 AMNYSE : GSK fda approvalGSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and olderGSK plc today announced that the US Food and Drug Administration has approved PRIORIX for active immunisation for the prevention of measles, mumps and rubella in individuals 12 months of age and older. PRIORIX is currently licenced in more than 100 countries worldwide, including all European countries, Canada, Australia and New Zealand, with more than 800...RHEA-AInegative
06/02/22 3:16 PMNYSE : GSK /C O R R E C T I O N -- GSK Consumer Healthcare/In the news release, The Food Fight is Over: TUMS® Declares It is Time to Love Food Back, issued 02-Jun-2022 by GSK Consumer Healthcare over PR Newswire, we are advised by the company that the links for TUMSworthy.com were updated to the correct websites in three instances throughout theRHEA-AIpositive
06/02/22 12:37 PMNYSE : GSK The Food Fight is Over: TUMS® Declares It is Time to Love Food BackGlaxoSmithKline (LSE: GSK) (NYSE: GSK) – Go ahead and revel in that ramen, indulge on pizza and savor even the sauciestRHEA-AIpositive
06/01/22 8:27 AMNYSE : PFE, GSK Pfizer Provides Update on Ownership Interest in HaleonPfizer Inc. today provided an update on its ownership interest in Haleon plc, the newly independent company which will hold the joint Consumer Healthcare business of GSK plc and Pfizer following the demerger of approximately 80% of GSK’ s ownership interest in the business to GSK’ s shareholders. Following the demerger and listing of Haleon on the London Stock...RHEA-AIneutral
05/04/22 9:30 AMNYSE : GSK Voltaren Teams Up with Actress Jennie Garth to Support Caregivers Nationwide1 in 5 Americans provide careRHEA-AIneutral
05/02/22 3:19 PMNYSE : GSK, PFE MOBI Makes Their Post-Pandemic NYC DebutMobilizing Our Brothers Initiative (MOBI) is teaming up with local NewRHEA-AIpositive
04/13/22 2:05 AMNasdaq, NYSE : SRRA, GSK acquisitionlow floatGSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bnGlaxoSmithKline plc and Sierra Oncology, Inc today announced that the companies have entered into an agreement under which GSK will acquire Sierra Oncology, a California- based, late-stage biopharmaceutical company focused on targeted therapies for the treatment of rare forms of cancer, for $55 per share of common stock in cash representing an approximate...RHEA-AIpositive
04/06/22 10:00 AMNYSE : GSK covid-19New Large-Scale Observational Study Shows COVID-19 Could Create Vulnerability to Shingles for People Age 50+According to a new study conducted by GSK, people age 50 or older in the US who have had COVID-19 may be at greater risk of developing shingles– a painful rash– compared to those who haven’ t been diagnosed with COVID-19. This research was published in the Infectious Diseases Society of America’ s Open Forum Infectious Diseases.. “This is the first epidemiological...RHEA-AInegative
03/29/22 1:30 PMNYSE : PFE, GSK fda approvalViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Virologically Suppressed Adolescents Living With HIV Who Are 12 Years of Age or Older and Weigh at Least 35 kgViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi B.V. as shareholders, today announced that the US Food and Drug Administration has approved Cabenuva for the treatment of HIV-1 in virologically suppressed adolescents who are 12 years of age or older and weigh at least 35 kg on a stable...RHEA-AIneutral